Skip to content

Novel Droplet Microfluidic Assay on a Chip Platform For Immune Profiling in Cancer Immunotherapy

Northeastern spinout, Feromics, is developing ScanDrop to track single cells from assay to omics, with special uses in cancer immunotherapy

Published: 25th July 2022
Novel Droplet Microfluidic Assay on a Chip Platform For Immune Profiling in Cancer Immunotherapy
Source: luchschenF, stock.adobe.com/uk/81178249, stock.adobe.com/
IP Status
  • Patented
Seeking
  • Development partner
  • Commercial partner
  • University spin out
  • Seeking investment